Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / South Korea

Bukwang Launches New Hepatitis Drug

November 2006 | Company Finance Alert

South Korean drugmaker Bukwang Pharmaceutical has received the green light from the Korean Food & Drug Administration (KFDA) for its new Hepatitis B treatment, Levovir. The drug has taken over ten years to develop and is reported to be the eleventh innovative medicine produced by Korea's pharmaceutical R&D sector.

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *

Forgotten your password?

If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.

Free Trial To Pharmaceuticals & Healthcare Insight

TAKE A TRIAL >>
Related Insight Articles
Korea's Low Health Spend Set To Continue

Companies / South Korea South Korea has the lowest healthcare expenditure out of all Organisation for Economic Co-operation and Development (OECD) members. The country spent just 5.6% of its GDP on health in 2004, with average...
August 2006
South Korea Announces Off-Patent Drug Price Cut

Companies / South Korea South Korea's government has announced that the reimbursement price for brand name drugs will be immediately reduced by 20% upon patent expiry. The news comes after calls for greater disclosure concerning...
August 2006
Pharma Market Access Barriers Overshadow South Korea-US FTA Talks

Companies / South Korea Local press reports claim that talks between the US and South Korea concerning a potential Free Trade Agreement are beginning to stall with pharmaceutical industry identified as one area of contention....
June 2006
South Korea To Introduce Positive List

Companies / South Korea South Korea is planning to introduce a positive list for the reimbursement of pharmaceuticals under the National Health Insurance (NHI) scheme. The Health Ministry is aiming to have the new system in...
June 2006
South Korea Plans New Drug Spending Cuts

Companies / South Korea South Korea is planning a number of cost-cutting initiatives designed to reduce drug expenditure, according to local press reports. The greatest controversy is likely to be generated by plans to cut...
June 2006


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2008 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS